RSV remains a leading cause of severe respiratory illness and hospitalization among infants worldwide. To understand early implementation experiences and emerging evidence, partners convened a global meeting in Santiago, Chile, on August 26–28, 2025, bringing together countries that have introduced — or are preparing to introduce — maternal RSV vaccination programs and monoclonal antibody delivery for infants. Read more.
